Qureight Ltd, a Core Imaging Laboratory developing deep-learning image analytics, and Vicore Pharma, a clinical-stage biopharmaceutical company unlocking the potential of angiotensin II type 2 ...
Pope Francis has been hospitalized at Gemelli since Friday, February 14. The latest medical bulletin confirms bilateral ...
Pneumonia is an infection of the lungs that can be caused most commonly by bacteria or viruses, such as Streptococcus ...
Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...
A real-world study in children with cystic fibrosis in the Netherlands found significant improvements in small airway ...
A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
A new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...